Introduction {#Sec1}
============

Fluoride is a common mineral found in soil, water, and various foods. As excessive and prolonged intake of fluoride can cause diseases such as dental fluorosis, skeletal fluorosis, and the weakening of bones, low doses of fluoride have been shown to reduce tooth decay and improve oral health without health risks. The action of fluoride on bone has been studied extensively, and the effects of fluoride on the physical properties of bone are well documented. As the dose of fluoride is certainly a factor in affecting bone quality and growth, recent studies have looked at how fluoride affects the bone signaling pathway, leading to changes in the bone \[[@CR1]--[@CR3]\].

The formation of bone and the development of the skeletal system require the coordinated activities of multiple signaling proteins, such as bone morphogenetic proteins (BMPs). BMPs belong to the biggest member of the transforming growth factor beta (TGF-β) family of growth and differentiation factors \[[@CR4]\]. Like other members of the TGF-β superfamily, BMPs exert their biological functions via interaction with two different types of serine/threonine kinase receptors-termed types I and II. Signals from the type I receptor, when phosphorylated by the type II receptor, are transmitted to the downstream substrates through various molecules, the most important among them being *Drosophila* mothers against decapentaplegic protein (Smads). Subsequent activation of target genes by Smads signaling is essential for bone development.

Smads are classified into three subgroups according to their functions: (1) pathway-restricted Smads (R-Smads: Smad1, Smad2, Smad3, Smad5, Smad8, and Smad9). (2) Common partner Smads (Co-Smad: Smad4) that provide R-Smads with DNA binding properties. (3) Inhibitory Smads (I-Smads: Smad6 and Smad7) \[[@CR5]\]. Upon the stimulation of BMPs ligand, R-Smads are phosphorylated by the serine/threonine kinase of the type I receptor and forms a heteromeric complex with the Co-Smad, Smad4. The complex is then translocated into the nucleus to regulate the transcription of target genes in conjunction with other nuclear cofactors, such as osteocalcin (BGP) and bone alkaline phosphatase (BALP). BGP and BALP are marker genes of cell viability and differentiation of osteoblast. I-Smads interfere with the type I receptor activation of R-Smads, thus hindering the assembly of R-Smads with Co-Smad. Although the downstream signaling of the BMP-2/Smad pathway leading to osteoblast differentiation has been extensively investigated, the changes of Smads remain poorly understood.

Human osteosarcoma Saos-2 cells have been shown to contain extractable bone-inducing agents that possess osteoblastic properties known for inducing differentiation \[[@CR6], [@CR7]\]. Recent findings from molecular studies suggest that BMPs differ from other osteogenic compounds. Many signaling pathways with diverse functions have been found to play a role in BMP/Smads-mediated osteogenesis. Several of these pathways are also critical in the differentiation of other cell lineages, including chondrocytes and osteoblasts. Although fluoride has been known to affect bone cells, relatively little is known about the specific mechanisms responsible for these effects. This study aims to summarize our current knowledge of BMP/Smads-mediated osteogenesis by presenting recently completed work which may help us to further elucidate the mechanisms of fluoride-induced Saos-2 cells differentiation.

Materials and Methods {#Sec2}
=====================

Cell Culture and Conditioned Medium {#Sec3}
-----------------------------------

The human osteoblast-like cell line (Saos-2) was obtained from the American Type Culture Collection, derived from a human osteosarcoma \[[@CR8], [@CR9]\]. The cell line used in the study were maintained in IMDM and RPMI-1640 (Hyclone Laboratories, Beijing, China) medium supplemented with 10 % fetal bovine serum and penicillin/streptomycin mixture (100 U/mL penicillin G, 100 μg/mL streptomycin sulfate; Hyclone Laboratories, Beijing, China) at 37 °C in a humidified atmosphere of 95 % air and 5 % CO~2~. After a 36-h attachment, cells were grown to 80 % confluence, and the medium was replaced with serum-free medium and then various doses of NaF were added.

Cell Proliferation {#Sec4}
------------------

Saos-2 cells were seeded into 96-well flat-bottomed plates at a density of 5 × 10^3^ cells/well, and then incubated with 0, 0.1, 0.2, 0.4, 0.8, and 1.6 mM NaF for 24, 48, and 72 h. Cell proliferation was determined using WST-8 dye (Cell Counting Kit-8/CCK-8, Beyotime, Jiangsu, China) according to manufacturer's instructions. After 10 μL WST-8 dye was added to each well, cells were incubated at 37 °C for 2 h and the absorbance was measured at 450 nm using a microplate reader (Bio-Rad, Hercules, USA). The experiment was repeated six times, and the mean value was calculated for each NaF concentration.

Quantitative Real-Time PCR {#Sec5}
--------------------------

Saos-2 cells were exposed to NaF, and total RNA was isolated using a Fast Pure RNAKit (Takara Bio, Shiga, Japan) according to the manufacturer's instructions. For reverse transcription reaction, cDNA was synthesized from total RNA (1.0 μg/reaction) using Reverse Transcription kit (Promega, Madison, USA) at 42 °C for 60 min and then 95 °C for 10 min. Quantitative real-time PCR (Q-PCR) was performed in a total reaction volume of 20 μL with an Real Master Mix (SYBR Green) kit (Tiangen Biotech, Beijing, China) per well using 1.0 μL of cDNA template and the appropriate primer for the target genes and normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The primer sequences and annealing temperatures are shown in Table [1](#Tab1){ref-type="table"}. Q-PCR amplifications were performed in a capped 8-well optical plate. The reaction conditions were as follows: 2 min at 95 °C, 40 cycles of 20 s at 95 °C, and 10 s at 68 °C. Fluorescence of the gene specific Q-PCR products was continuously measured and used for quantitative purposes. At the end of the amplification period, melting curve analysis was performed to confirm the specificity of the amplicon. Relative quantification of gene expression was calculated by using 2^−∆∆CT^ equation. All data derived using Q-PCR was from multiple experiments with at least triplicate independent biological samples.Table 1RT-qPCR primers for gene expression analysisPrimerGenBank accession no.Sequence(5′-3′)Annealing temperature (°C)BALPNM_000478.4F:CATCCTGTATGGCAATGGG56R:CATCCTGTATGGCAATGGGBGPNM_199173.3F:AGGGCAGCGAGGTAGTGA57R:CCTGAAAGCCGATGTGGTSmad4NM_005359.5F:CCATCATAACAGCACTACC55R:CGTATCCATCAACAGTAACAGAPDHNM_002046.3F:GGATTTGGTCGTATTGGG56R:GGAAGATGGTGATGGGATT

Immunofluorescence {#Sec6}
------------------

The cells exposed to NaF for 72 h were fixed with 4 % paraformaldehyde for 30 min. They were then permeabilized in PBS/0.2 % Triton X-100 for 10 min and blocked with 3 % bovine serum albumin in PBS for 30 min. The cells were then incubated with primary antibodies overnight. Mouse monoclonal anti-Smad1 antibody (Abcam, Cambridge, UK) and phosphorylated rabbit polyclonal anti-Smad1/5 antibody (Cell Signaling Technology Inc., Danvers, USA) mixed together were used at 1:50, Mouse monoclonal anti-Smad5 antibody (Abcam, Cambridge, UK) and phosphorylated rabbit polyclonal anti-Smad1/5 antibody(Cell Signaling Technology Inc., Danvers, USA) mixed together was used at 1:50, rabbit polyclonal anti-Smad4 antibody (Cell Signaling Technology Inc., Danvers, USA) was used at 1:50. Cells were washed three times in PBS and then stained with the mixed secondary antibodies for 60 min. DayLight 405-conjugated goat anti mouse antibody (1:100; EarthOx Biotech Inc., San Francisco, USA) and Cy3-conjugated goat anti rabbit antibody (1:200; Beyotime, Jiangsu, China) were mixed together. FITC-conjugated goat anti rabbit antibody (Boster Biotech Inc., Wuhan, China) was used at 1:60. The expression and locations of Smads in Saos-2 cells were observed using a C1 plus (Nikon Corp., Tokyo, Japan) lasers scanning confocal microscope and processed using Adobe Photoshop.

ShRNA and Transfection {#Sec7}
----------------------

Four pairs of green fluorescent protein (GFP)-labeled shRNA targeting Smad4 corresponding to the respective coding regions were designed and synthesized by custom-made plasmid vectors (GenePharma Corp., Shanghai, China) and used according to the manufacturer's protocols. The nonsense sequence with no similar match to any known sequence was used as control. The Smad4-shRNA1 sequence: CTGCCAACTTTCCCAACAT; the Smad4-shRNA2 sequence: GCCTCCCATTTCCAATCAT; the Smad4-shRNA3 sequence: CGGTCTTTGTACAGAGTTA), and the nonsense sequence to Smad4 was named negative control shRNA (NC-shRNA: GGTGTGCAGTTGGAATGTA). All shRNA sequences were compared against human sequences deposited in GenBank™ databases with BLAST (Basic Local Alignment Search Tool) searches using the NCBI (National Center for Biotechnology Information) tools. Plasmid stocks were titrated by infection in Saos-2 cells and assessed by GFP fluorescence. For shRNA experiments, Saos-2 cells were grown overnight in 6-well plates. Cells were transfected with 20 ng/ul of shRNA using X-tremeGENE HP DNA™ (Roche Diagnostics GmbH, Mannheim, Germany) as instructed by the manufacturer. After transfection, Smad4 suppression was analyzed by Q-PCR to confirm gene knockdown. Treatment with fluoride, the expression of BGP and BALP were determined after Smad4-shRNA transfection.

Statistical Analysis {#Sec8}
--------------------

Results were presented as means ± SEM. Each value represents the mean of at least three repetitive experiments in each group. ANOVA was used to analyze groups with more than two sets of data, and Student--Newman--Keuls post hoc analysis was used to compare groups of data. *T* test was used to compare the effect of the compounds and their difference from the untreated control. All statistical calculations were processed using the SPSS 13.0 (SPSS Inc., Chicago, IL, USA) software. Values of *P* \< 0.05 were considered significant.

Results {#Sec9}
=======

As shown in Fig. [1](#Fig1){ref-type="fig"}, the survival rates of Saos-2 cell increased as fluoride concentration increased at both 48 and 72 h post-treatment with fluoride, except at 1.6 mM. Moreover, Saos-2 cells with 0.2 mM fluoride over 72 h exhibited significantly higher level of proliferation compared with other concentrations. Thus, fluoride-induced Saos-2 cell osteoblast marker genes expression was examined at the concentration of 0.2 mM fluoride for 72 h.Fig. 1Growth curve of fluoride-treated Saos-2 cells. Saos-2 cells were seeded into 96-well plates and cultured with different concentrations of NaF for 24, 48, and 72 h as indicated in the "[Materials and Methods](#Sec2){ref-type="sec"}." The WST assay was performed to quantify the cytotoxicity of fluoride to Saos-2 cells. *Asterisk* indicate the significant differences

Subsequently, we found that treatment with fluoride enhanced the expression of BGP and BALP, the early markers of osteoblast differentiation, compared with the control group (Fig. [2](#Fig2){ref-type="fig"}). These results demonstrate that fluoride at a dose of 0.2 mM promotes the osteoblastic differentiation of Saos-2 cells.Fig. 2Quantitative RT-PCR results of BALP and BGP mRNA in fluoride-treated Saos-2 cells. Saos-2 cells were treated with NaF over 72 h and subjected to real-time RT-PCR analysis using specific primers. Expression was quantified by the 2-∆∆CT method. Gene expression was determined in triplicate, normalized with GAPDH, and is graphed relative to expression. \**P* \< 0.05, compared with the control group

We further found that Smad1, Smad5, and p-Smad1/5 were present in the cytoplasm and nucleus of Saos-2 cells (Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}), and Smad4 exhibited that nuclear accumulation upon stimulation with 0.2 mM fluoride, compared with the control group (0 mM NaF) (Fig. [5](#Fig5){ref-type="fig"}). Upon NaF stimulation, both R-Smads accumulated in the cytoplasm and nucleus of Saos-2 cells (Figs. [3b](#Fig3){ref-type="fig"} and [4b](#Fig4){ref-type="fig"}), which was not significantly elevated compared with the control group (Figs. [3a](#Fig3){ref-type="fig"} and [4a](#Fig4){ref-type="fig"}). Likewise, Smad4 was not significantly changed after stimulation by 0.2 mM fluoride (Fig. [5b](#Fig5){ref-type="fig"}). Therefore, fluoride did not significantly change the protein level of total R-Smads and Co-Smad, but the levels of R-Smad phosphorylation significantly increased (Figs. [3c, d](#Fig3){ref-type="fig"} and [4c, d](#Fig4){ref-type="fig"}).Fig. 3Content of Smad1 and p-Smad1/5 protein in fluoride-treated Saos-2 cells. Laser scanning confocal microscopy was used to detect expression of Smad1 and p-Smad1/5 proteins after exposure to NaF (200×). **a**, **c** Control (0 mM NaF) and **b**, **d** 0.2 mM NaF groups; **a**, **b** Smad1 and **c**, **d** p-Smad1/5. Three wells were assayed for each experimental treatment, and three separate experiments were performedFig. 4Content of Smad5 and p-Smad1/5 protein in fluoride-treated Saos-2 cells. Laser scanning confocal microscopy was used to detect expression of Smad5 and p-Smad1/5 proteins after exposure to NaF(200×). **a**, **c** Control (0 mM NaF) and **b**, **d** 0.2 mM NaF groups; **a**, **b** Smad5 and **c**, **d** p-Smad1/5. Three wells were assayed for each experimental treatment, and three separate experiments were performedFig. 5Content of Smad4 protein in fluoride-treated Saos-2 cells. Laser scanning confocal microscopy was used to detect expression of Smad4 proteins after exposure to NaF (200×). **a** Control (0 mM NaF) and **b** 0.2 mM NaF groups. Three wells were assayed for each experimental treatment, and three separate experiments were performed

Finally, we detected if Smad4 silencing abrogates fluoride-induced Saos-2 cells differentiation, shRNAs were designed to target on the human Smad4 mRNA (Fig. [6a](#Fig6){ref-type="fig"}). The RNAi efficiency in Saos-2 cells was evaluated by RT-qPCR. The Smad4 shRNA1, shRNA2, and shRNA3, which targeted different Smad4 cDNA sequences respectively, reduced the levels of Smad4 mRNA expression, with shRNA3 being more effective than others (Fig. [6b](#Fig6){ref-type="fig"}), but the expression of Smad4 was not remarkably suppressed by mismatch shRNA interference at the mRNA level (Fig. [6b](#Fig6){ref-type="fig"}). Given that the RNAi effect by shRNA3 was found to be the most reproducible, shRNA3 was used for the subsequent RNAi experiments. As shown in Fig. [7](#Fig7){ref-type="fig"}, treatment with fluoride enhanced the expression of BGP and BALP compared with the control group, whereas blocking BMP/Smad signaling inhibited the upregulated expression of BGP and BALP induced by fluoride, suggesting that inhibition of the BMP/Smad signaling interrupts fluoride-induced Saos-2 cells differentiation.Fig. 6Effects of shRNAs against Smad4 mRNA. **a** Transfection efficiency of Smad4-shRNA observed by laser scanning confocal microscopy (200×); **b** quantitative RT-PCR showing expression of Smad4 mRNA in Saos-2 cells following infection with shRNA1,2,3 and mismatch shRNA. Gene expression was determined in triplicate, normalized with GAPDH and is graphed relative to expression. \**P* \< 0.05, compared with the control groupFig. 7Inhibition of BMP/Smad signaling inhibits fluoride-induced Saos-2 cells differentiation. Gene expression was determined by quantitative RT-PCR, normalized to GAPDH expression, and is graphed relative to the expression. \**P* \< 0.05, compared with the control group; \#*P* \< 0.05, compared with the group only treated with fluoride

Discussion {#Sec10}
==========

BMP signaling plays a significant role in osteoblast differentiation. However, how BMP/Smads signaling drive transdifferentiation for osteoblasts differentiation remains unclear. In this study, we found that fluoride significantly enhanced the proliferation of Saos-2 cells, which is consistent with the findings of Lau and Baylink \[[@CR10]\], that BMP/Smad signaling becomes activated in Saos-2 cells during their differentiation, and that the activation of Smads during Saos-2 cells differentiation was due to phosphorylation of R-Smads, rather than enhancement in total R-Smads and Co-Smad.

Emerging evidence indicates that fluoride acts directly on cells of the osteoblast lineage to promote their development and/or activity. Okamoto et al. showed that increased BMP4 signaling in vivo stimulated osteoblast \[[@CR11]\]. Chen et al. showed that a peak expression for type I collagen occurred in the early phase (day 1) of fetal rat calvarial osteoblasts \[[@CR12]\]. BGP is the most abundant noncollagenous protein in bone and is present in the bone matrix and synthesized by osteoblasts \[[@CR13], [@CR14]\]. Van Straalen et al. showed that bone-alkaline phosphatase is a useful parameter for monitoring changes in bone formation \[[@CR15]\]. Accumulation of these bioactive molecules in vitro could potentially induce proliferation and differentiation of osteoblasts and result in the formation of new bone \[[@CR16]\]. In our present study of Saos-2 cells, the expression of two markers for osteoblastic differentiation---BGP and BALP mRNAs---were significantly increased by fluoride. The expression of BALP and BGP were higher in the fluoride group than the control group. However, the expression of BGP was not significantly increased as the expression of BALP (Fig. [2](#Fig2){ref-type="fig"}). This led us to assume that BALP is more sensitive in monitoring osteoblast-like Saos-2 cells formation and differentiation.

BMP signals through the type II receptor, encoded by different genes in combination with the type I receptors \[[@CR17]--[@CR19]\]. The type I receptors, BMP-RIA and BMP-RIB, have been shown to stimulate osteoblastic differentiation in preosteoblastic cell lines \[[@CR20]\]. Some scholars indicated that C2C12 myoblasts can be induced to express some early osteoblast markers in response to elevated BMP signaling \[[@CR21], [@CR22]\]; however, this stimulation was inadequate for osteoblast differentiation. BMPs form a unique group of proteins within the transforming growth factor-β super-family and have a pivotal role in the regulation of bone induction, maintenance and repair \[[@CR23], [@CR24]\]. BMPs stimulate the activation of Smad proteins that accumulate in the nucleus and control the transcription of a large number of target genes. Smad1, Smad5, and Smad8 are recognized by BMP type I receptor, which play important roles in osteoblast differentiation \[[@CR24]\]. Smad1 and Smad5 have been shown to be the major signaling molecules for inducing differentiation of C2C12 cells into osteoblasts \[[@CR25]\]. Several studies have shown that Smad1/5/8 could form heteromeric complexes with Co-Smad Smad4 and translocate into the nucleus where they regulate transcription of various target genes \[[@CR26]\]. In our study, we found that phosphorylations of Smad1/5 are equally enhanced in fluoride-treated Saos-2 cells; however, there is very little difference between fluoride-treated and control cultures in total Smad1 and Smad5, which demonstrates that an activation of fluoride-induced Saos-2 cells differentiation was due to dephosphorylation of Smad1 and Smad5, rather than enhanced expression of total Smad1 and Smad5. The role of Smad4 in the phases of osteoblast-differentiating process remains unclear. In the present study, fluoride had no effect on the protein level of Smad4. It is possible that partially functional Smad4 interacted with phosphorylationed Smad1/5 to form hetero-oligomeric complexes which translocate into the nucleus to regulate the transcription of various target genes, as the total level of Smad4 have not significantly change.

Taken together, we demonstrated that fluoride induces Saos-2 cells differentiation in parallel with the phosphorylations of Smad1/5, which then mediated differentiation via activation of Smad signaling. We therefore conclude that the BMP/Smad pathway plays a role in fluoride-induced differentiation of Saos-2 cells.
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